96838 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA
#2Vaccines against Chlamydia sp.
#3Compositions for use in treatment of
#4BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS
#5CHLAMYDIA VACCINE BASED ON TARGETING MOMP VS4 ANTIGEN TO ANTIGEN PRESENTING CELLS
#6CHLAMYDIA TRACHOMATIS ANTIGENIC POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSES
#7IMPORT OF UNNATURAL OR MODIFIED NUCLEOSIDE TRIPHOSPHATES INTO CELLS VIA NUCLEIC ACID TRIPHOSPHATE TRANSPORTERS
#8RECOMBINANT EXPRESSION OF CHLAMYDIA MOMP ANTIGEN
#9MULTI-EPITOPIC CONSTRUCT
#10Vaccines against Chlamydia sp.
#11RECOMBINANT CHLAMYDIA-ACTIVATED B CELL PLATFORMS AND METHODS OF USE THEREOF
#12Recombinant expression of MOMP antigen
#13CHLAMYDIA SUIS DIAGNOSIS
#14CHLAMYDIA NANOEMULSION VACCINE
#15Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
#16Chlamydia antigens
#17Vaccines against sp
#18Recombinant expression of MOMP antigen
#19Compositions for and methods of identifying antigens
#20Multi-epitopic construct
#21CHLAMYDIA ANTIGENS
#22Method and peptides for the detection of
#23Methods and compositions for attenuated chlamydia as vaccine and vector
#24Methods and compositions for vaccinating a subject for a sexually transmitted pathogen
#25Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
#26Chlamydia vaccine
#27Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
#28Chlamydia antigens
#29Compositions for and methods of identifying antigens
#30OMV vaccines
#31CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF
#32Vault compositions for immunization
#33Vault compositions for immunization
#34Vaccines for
#35CHLAMYDIA ANTIGENS
#36VACCINES AGAINST CHLAMYDIAL INFECTION
#37OMV vaccines
#38Chimeric MOMP antigen
#39IMMUNIZATION AGAINST CHLAMYDIA PNEUMONIAE
#40Vault compositions for immunization against Chlamydia genital infection
#41Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#42COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#43Chlamydia antigens
#44Hybrid prokaryotic-eukaryotic tubulins and use thereof
#45CHLAMYDIA ANTIGENS AND USES THEREOF
#46vectored vaccines against and methods of use
#47Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
#48NOVEL DEATH DOMAIN PROTEINS
#49genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
#50Immunogenic compositions for
#51Compounds and methods for treatment and diagnosis of chlamydial infection
#52MUTANT FORMS OF CHLAMYDIA HTRA
#53Compositions for and methods of identifying antigens
#54Chlamydia vaccine
#55antigens
#56CHLAMYDIA ANTIGENS
#57CHLAMYDIA PNEUMONIAE ANTIGENS
#58CHLAMYDIA ANTIGENS
#59Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#60antigens
#61IMMUNIZATION AGAINST CHLAMYDIA PNEUMONIAE
#62Vault compositions for immunization against chlamydia genital infection
#63antigens for vaccine and diagnostic use
#64OMP antigen
#65genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
#66CHLAMYDIA PNEUMONIAE POLYNUCLEOTIDES AND USES THEREOF
#67Two-Step Immunization Procedure Against Chlamydia Infection
#68OMP P6 VACCINE FOR TREATING AND PREVENTING CHLAMYDIA INFECTION
#69Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof
#70Chlamydia antigens and protein vaccine
#71polypeptides and corresponding DNA fragments and uses thereof
#72COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#73COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#74Chlamydia Antigens and Uses Thereof
#75COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#76VACCINES AGAINST CHLAMYDIAL INFECTION
#77NOVEL DEATH DOMAIN PROTEINS
#78COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#79Compounds and methods for treatment and diagnosis of chlamydial infection
#80Novel surface exposed proteins from chlamydia pneumoniae
#81SECRETED CHLAMYDIA POLYPEPTIDES, POLYNUCLEOTIDES CODING THEREFOR, THERAPEUTIC AND DIAGNOSTIC USES THEREOF
#82COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#83Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#84COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#85Two-step immunization procedure against chlamydia infection
#86COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#87COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#88Immunization Against Chlamydia Infection
#8960 Kda CRMP antigens and vaccine uses
#90Chlamydia OMP antigen
#91Two-step immunization procedure against chlamydia infection
#92flagellar protein antigen
#93Immunization Against Chlamydia Infection
#94PMP proteins, gene sequences and uses thereof
#95PMP proteins, gene sequences and uses thereof
#96Compositions capable of facilitation penetration across a biological barrier
#97Immunisation against Chlamydia pneumoniae
#98polynucleotides and uses thereof
#99Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
#100Amino acid sequences capable of facilitating penetration across a biological barrier
#101Chlamydia pneumoniae antigens
#102Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
#103Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#104Chlamydia trachomatis antigens
#105Recombinant pgp3 protein suitable for enzyme-linked immunoassay, and used of the protein in eliciting and diagnosing an immune response
#106Vaccine composition
#107Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#108Peptides for chlamydophila pneumoniae vaccine and diagnosis
#109Method for identification of proteins from intracellular bacteria
#110Compounds and methods for treatment and diagnosis of chlamydial infection
#111outer membrane protein (OMP) and vaccine uses of the protein
#112Amino acid sequences capable of facilitating penetration across a biological barrier
#113antigens and vaccine uses of the protein
#114Novel death domain proteins
#115antigens and corresponding DNA fragments and uses thereof
#116Cytotoxic T-cell epitopes from
#117Chlamydia antigens and corresponding DNA fragments and uses thereof
#118Compositions capable of facilitating penetration across a biological barrier
#119DNA immunization against infection
#120Compounds and methods for treatment and diagnosis of chlamydial infection
#121Chlamydia antigens and corresponding DNA fragments and uses thereof
#122Expression library immunization
#123Chlamydia protein, gene sequence and uses thereof
#124Diagnosis and management of infection caused by chlamydia
#125Vaccines for infections
#126antigens and corresponding DNA fragments and uses thereof
#127Chlamydia antigens and corresponding DNA fragments and uses thereof